<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>A Mant&#039;s World | Macias Martinsen | Activity</title>
	<link>https://www.mantworld.com/members/airbussilver92/activity/</link>
	<atom:link href="https://www.mantworld.com/members/airbussilver92/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Macias Martinsen.</description>
	<lastBuildDate>Fri, 24 Apr 2026 00:56:10 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7e1b1fb717d9ae4019b1974586154beb</guid>
				<title>Macias Martinsen posted an update: Stable overexpression with the triglyceride lipase adipose [&#133;]</title>
				<link>https://www.mantworld.com/activity/p/80183/</link>
				<pubDate>Wed, 14 Dec 2022 13:37:20 +0000</pubDate>

									<content:encoded><![CDATA[<p>Stable overexpression with the triglyceride lipase adipose triglyceride lipase (ATGL) decreased IMTG content inside myotubes, but led to the concomitant boost in diacylglycerol (DAG) as well as ceramide and triggered insulin <a href="https://www.selleckchem.com/products/ap-3-a4-enoblock.html" rel="nofollow ugc">buy AP-III-a4</a> weight. Escalating TG content material through muscle-specific overexpression involving diacylglycerol&hellip;<span class="activity-read-more" id="activity-read-more-80183"><a href="https://www.mantworld.com/activity/p/80183/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1a49c1e0667bae57cab67f1fff0b3f20</guid>
				<title>Macias Martinsen posted an update: MethodsPatients with metastatic/recurrent SCCHN were helped [&#133;]</title>
				<link>https://www.mantworld.com/activity/p/72052/</link>
				<pubDate>Sun, 04 Dec 2022 09:01:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>MethodsPatients with metastatic/recurrent SCCHN were helped by gemcitabine (3000 mg/m2) and also paclitaxel (150 mg/m2) upon nights One and 15 of every 28-day never-ending cycle. ResultsIn 57 individuals using considerable illness, mean progression-free success (PFS) was Some several weeks and median total survival (Operating system) ended up&hellip;<span class="activity-read-more" id="activity-read-more-72052"><a href="https://www.mantworld.com/activity/p/72052/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">17772e98760412730b63f142aaabb444</guid>
				<title>Macias Martinsen became a registered member</title>
				<link>https://www.mantworld.com/activity/p/71796/</link>
				<pubDate>Sun, 04 Dec 2022 08:45:27 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>